Monday, 18 May 2020

Updates 2020: Ligation Devices Market trends Moving toward 2024

Market research future will be publishing a Half cooked research report on “Global Ligation Devices Market trends ” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.
Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.
Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.
Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.
Regional Analysis
The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.
In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.
On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

News Update Hemophilia treatment drugs market Size, Trends Research and Reprot

Hemophilia refers to an inherited genetic blood disorder which affects the ability of the blood to clot due to the lack of a specific protein required for blood clotting. As per the analysis of Market Research Future (MRFR), the global hemophilia treatment market is likely to post a CAGR of 6.10% over the forecast period of 2018-2023. The global hemophilia treatment market was valued at USD 11,257.21 in 2017 and is due to reach a valuation of USD 16,059.17 by the end of 2023. 

The prevalence of hemophilia is found to be high across the globe, and it is in the backdrop of such high prevalence of hemophilia, the global hemophilia treatment drugs market is expanding steadily. The World Federation of Hemophilia estimates the number of people suffering from hemophilia in the US to be close to 17,000. 

An outlay of massive amounts by biotechnology companies and high government support for R&D activities has resulted in significant developments in recent years. Recombinant products have emerged as an alternative to plasma-derived products and consumers have demonstrated an increased inclination towards the use of recombinant products which can also be credited for the growth of the global hemophilia treatment market. Recombinant products, is derived from genetically engineered cells at are zero risks of contamination. 

On the downside, the market growth might be deterred by the high costs associated with hemophilia treatment which restricts the growth of the market in cost-sensitive markets. Hemophilia treatment involves a variety of technologically high-end products which limits the patient pool opting for treatment. 

Segmentation
The global hemophilia treatment market has been segmented based on type, treatment type, and end user. 

By type, the global hemophilia treatment market has been segmented into hemophilia A, hemophilia B, and hemophilia C. The hemophilia A segment is the largest segment and is expected to reach a valuation of USD 12,697.99 at a CAGR of 6.23% by the end of the forecast period. 

By treatment type, the global hemophilia treatment market has been segmented into Plasma-derived coagulation factor concentrate, Recombinant coagulation factor concentrates, Desmopressin, Antifibrinolytic agents, and Gene Therapy. The recombinant coagulation factor concentrates segment is likely to expand at the highest CAGR of 7.01% over the forecast period. 

By end user, the global hemophilia treatment market has been segmented into hospitals & clinics, research organizations, and others. The hospitals & clinics segment accounted for the largest share of USD 7594.66 in 2017 and is also anticipated to showcase the fastest growth over the forecast period. 

Regional Analysis
Geographically, the global hemophilia treatment market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). The Americas account for the lion's share of the global hemophilia treatment market and is likely to maintain its lead over the forecast period. The growth of the Americas market can be attributed to the high occurrence of the disorder in the region coupled with growing expenditure on the healthcare sector. The presence of an established healthcare sector and towering support for R&D activities acts as a plus for the market growth. 

Europe holds the second largest share of the global hemophilia treatment market and exhibits similar growth pattern as that of the Americas. The Europe hemophilia treatment market is driven by high government support for research and development to develop advanced medical therapies. 

APAC is poised to showcase the highest growth rate of 8.38% over the forecast period. Prolific improvement in the healthcare sector coupled with high demand for advanced treatment options stimulates the growth of the APAC hemophilia treatment market. The presence of a large patient pool is also a co0ntributing factor. 

Competitive Landscape
The key players in the global hemophilia treatment market include F.Hoffmann-La Roche Ltd, Bayer AG, Baxter, Pfizer Inc, Sanofi, Novo Nordisk A/S, Shire, Kedrion, CSL Behring, Octapharma, Swedish Orphan Biovitrum AB, and Grifols International S.A. 


Posted by at No comments:
Labels:

Healthcare news: Global spirometry market 2020: Industry Forecast to 2023

Market Insights
According to the reports published by Market Research Future Reports, the global spirometry market is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.
Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests. 
Global Spirometry Market: Drivers & Trends
The factors such as emerging chronic respiratory diseases globally, increasing global aging population, and technological shifts in spirometer devices toward smartphone-based data connectivity and analysis are expected to drive the global spirometry market exponentially during the forecast period. With that, emerging economies with growing industrialization are also contributing to driving the market with opportunities for the future in substantial ways. 
More stimulating factors such as government initiatives to restrain smoking habits of people, focus on breathing diseases, rising levels of air pollution, and expanding awareness towards the adoption of spirometers at homes are noticeably auguring the global spirometry market growth. Even awareness of reimbursement policies among the public and clinicians are also projecting to be the drivers for patients towards taking these tests. On the flip side, the high costs of spirometers may act as a restrictive factor against the market and hinder the global spirometry market growth.
Furthermore, the rising geriatric population is also anticipating being the factors for the increase in the demand for spirometers to analyze respiratory patterns. The need for spirometers is also probable in the rise due to a high number of surgeries in hospitals and clinics. These factors are tremendously driving the global spirometry market to rise high at a higher CAGR in the years to come. 
Segmental Overview
According to the reports published by MRFR, the global spirometry market has been segmented by product, technology, application, and end-user.
By the mode of products, the market includes table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. 
By the mode of technology, the market has been segmented into volume measurement spirometry, peak flow meters (PFM), and flow measurement spirometry.
By the mode of application, the spirometry market is segmented into diagnostic and treatment monitoring. 
Moreover, by the mode of end-users, the market includes research & academic institutes, diagnostic centers, hospitals & clinics, and home care.
Regional Outlook
Geographically, the market of spirometry has covered some main regions such as Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). 
Among these, Asia Pacific is expected to register the highest CAGR for the market to proliferate during the forecast period. Growth of this market in the Asia Pacific region is driven mainly by the large population of the patient and a high prevalence of chronic respiratory diseases.
While North America has the largest market for spirometers owing to technological advancements, government regulations, rise in incidences of respiratory diseases, increasing healthcare expenditure, and improved healthcare infrastructure.
Key Players
In the end, here are the prominent players in the spirometry market, they are Carefusion Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Nihon Kohden Corporation (Germany), MGC Diagnostics Corporation (U.S.), Vitalograph (U.K.), Schiller AG (Switzerland), COSMED srl (Italy), Hill-Rom Holdings, Inc. (U.S.), Midmark Corporation (U.S.), Smiths Medical Inc. (U.S.), and Koninklijke Philips N.V. (The Netherlands).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Posted by at No comments:
Labels:

Research On Cystic Fibrosis Therapeutic Market 2020 -Global Trends and Deman

Global Cystic Fibrosis Market that predicts the growth of the market with a substantial 13.8% CAGR during the forecast period of 2016-2022. The MRFR report also asserts that the cystic fibrosis market is a likely to achieve USD 1, 192.2 Mn valuation by 2022 end. 
The inherited chronic malaise namely cystic fibrosis (CF) causes accumulation of thick and sticky mucus in lungs and digestive system that leads to obstruction of the natural system which causes infection. Caused due to mutation in cystic fibrosis transmembrane conductance regulator (CFTR) protein gene, the disease has symptoms which include continuous respiratory infection, fatty stool, and loss of appetite. The treatment for cystic fibrosis is likely to compel the pharmaceuticals in manufacturing more effective drugs, thereby creating immense opportunity for the key players operating in the market to invest in research and developmental activities. 
Cystic fibrosis hinders all endocrinal hormone activities which can sometimes lead to infertility in men. Hence, early diagnosis is crucial. Medical advancements are expected to bring positive results in boosting the cystic fibrosis diagnostics techniques. These are important factors which are anticipated to promulgate market growth. The diagnosis and treatment of cystic fibrosis are expensive. This is an expected retarder of the global cystic fibrosis market. 
Key Players 
  • Vertex Pharmaceuticals
  • F. Hoffmann-La Roche
  • AbbVie
  • Gilead Sciences
  • Novartis
  • Genentech
  • Pharmaxis
  • Chiesi Pharmaceutics
  • Forest Laboratories and more.
Segmental Overview 
The global cystic fibrosis market segmentation by MRFR is based on treatment method. 
It offers a comprehensive study on the market. The treatment method is further narrowed down to medication, devices, and other treatments. The medication segment is anticipated to hold the maximum market share. This medication segment is estimated to grow with an impressive 14% CAGR during the upcoming years of 2016-2022. 
Regional Analysis 
MRFR in its report mentions a detailed regional analysis that gives a clear picture of the regional market drivers and restraints. Geographically, the cystic fibrosis therapeutics market
 study is segmented into North America, Asia Pacific, Europe, and Rest-of-the-World (RoW). 
The highest market share is likely to be owned by North America, with a valuation estimated to grow to USD 531 million by 2022 end. The region boasting of its technological advancements and medical infrastructure is impelling the cystic fibrosis market. 
The European cystic fibrosis market is expected to attain an astounding 14.1% CAGR in the forthcoming years owing to the European governmental healthcare benefits. 
The Asia Pacific region to experience a progressive cystic fibrosis market. However, in countries like China and Japan the occurrence rate of cystic fibrosis is relatively lower compared to the other countries of APAC. The economic backlog and deploring medical infrastructure in the Middle East Asia and Africa is impeding the cystic fibrosis market growth. 
To know more About Related Report with Top Companies at
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Posted by at No comments:
Labels:

Friday, 15 May 2020

Trends on Medication management market Companies to Forecast by 2023


Overview:
Medication management is a strategy to make patient realize the value of medications to ensure timely intake of those medicines. This also ensures that the medication process gets improved. The process includes several methods like medication reconciliation, patient/family education on medications, medication therapy management, and medication set-up simulations. The global medication management market has the potential to move forward with a CAGR of 13.4% over the review period of 2018 to 2023.
Several factors like rising geriatric population, better inclusion of healthcare IT, increased patient-physician interaction, and other app-related moves are expected to trigger the growth of the medication management market. The need to curb healthcare cost is also placing substantial reliance on the growth of the medication management market Companies.
Segmentation:
The global medication management market, as reported in the MRFR study, can be segmented by systems, services, mode of delivery, and end-user. This report provides insights regarding various factors that can impact the global market in the coming years.
Based on systems, the global medication management market can be segmented into computerized physician order entry systems, administration software, clinical decision support systems, automated dispensing systems, inventory management systems, and assurance systems. The administration software covers electronic medication administration records (eMAR) software and bar code medication administration (BCMA) software. The automated dispensing systems segment includes centralized automated dispensing systems and decentralized automated dispensing systems (ADS). The centralized automated dispensing system comprises robots/robotic automated dispensing systems and carousels. The decentralized automated dispensing system (ADS) is segmented on the basis of ward-based decentralized automated dispensing systems, pharmacy-based decentralized automated dispensing systems, and automated unit-dose decentralized automated dispensing systems.
Based on the services, the global medication management market can be segmented into point-of-care verification services and adverse drug effects (ADE) surveillance services.
Based on the mode of delivery, the medication management market includes web-based solutions, on-premise solutions, and cloud-based solutions.
Based on the end-user, the medication management market includes hospitals, pharmacies and others.
Regional Analysis:
The Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA) are regions that have been mentioned in the region-specific study of the global medication management market. This analysis relies a lot on the uncovering of various demographic challenges. 
The Americas has the better market dominance as the region hosts well-established healthcare infrastructures and technological support in countries like the U.S., Canada, Mexico, and others. At the same time, a lot of companies are launching their own ways of handling the procedure to ensure that the market never loses the influx of finance in the coming years. 
Europe’s growth is quite pervasive and relies on the dominance of developed economies like U.K., Germany, France, and others. These countries are spurring the growth of the regional market by initiating innovations.
The APAC region is expected to emerge as the fastest growing segment and this is expected to happen due to the growing inclusion of various latest technologies in the revamping infrastructure of healthcare sector in several countries. India and China are expected to contribute significantly.
The MEA region is expected to showcase moderate growth due to the lack in financial backup. Most of the countries from the African region are poor and hence, providing substantial backup to the market would be impossible for them.
Competitive Landscape:
Several competitors in the global medication management market are participating to take the market ahead. The process includes various strategic decisions like merger, acquisition, collaboration, and others. MRFR in their recent report on the global medication management market integrated companies like Mckesson Corporation, Allscripts Healthcare 0Electric Company, Inc., Medical Information Technology, Optum Inc., Omnicell, Inc., Siemens Ltd, QuadraMed Affinity Corporation, and others for a better understanding. Their profiling of these companies is to keep an eye on the latest trends and map the market movement. 
In August 2019, Molina Healthcare and Abarca decided to become partners in launching fresh ideas regarding predictive analytics into this market to cater to Molina Healthcare’s vulnerable members. 
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312


Posted by at No comments:
Labels:

Spirometry Market 2020 -Global Trends, Demand and sizing by Forecast to 2023

Market Insights
According to the reports published by Market Research Future Reports, the global spirometry market is probable to exhibit a 10.03% CAGR from 2018 to 2023 and is also on the verge to reach USD 1,106.76 million by 2023. Such a humongous market growth can be attributed to the strident rise in the cases of chronic obstructive pulmonary disorders (COPD) and asthma.
Spirometry is considered as a basic test, which is conducted by clinicians to estimate the status of lungs. It is an essential test for diagnosing asthma, COPD, and other breathing disorders.  Thus, spirometers are used to carry out the tests. 
Government initiatives to curtail smoking habits, focus on breathing diseases, rising levels of air pollution, and adoption of spirometers at homes are factors likely to augur market growth. Awareness of reimbursement policies among the public and clinicians are projected to drive patients towards taking these tests. But high costs of spirometers can act as a deterrent against market growth.
Spirometry Market Segmentation:
The spirometry market can be segmented by product, technology, application, and end-user.
By product, the market is segmented into table-top spirometry, hand-held spirometry, and desktop (PC) spirometry. The table-top spirometry segment accounted for 49.9% market share in 2017, followed by hand-held (31%), and desktop (19.1%). This can be attributed to adoption of spirometers in hospitals and clinics. But the desktop segment is touted to register the highest CAGR of 10.58% during the forecast period owing to its rapid diagnosis rate and increasing use of computer-based applications.
By technology, the market covers flow measurement spirometry, volume spirometry, and peak flow meters (PFM). The flow measurement spirometry segment accounted for 50.3% share in 2017. This can be attributed to its lightweight nature and compact size. Its functionality based on the familiar table-top spirometer technology and lack of frequent calibration make it popular among clinicians. But the PFM technology can register 10.58% CAGR over the forecast period to reach USD 149.76 million by 2023.
Major applications of the spirometry market include diagnostic and treatment monitoring. The diagnostic segment is further sub-segmented into asthma, interstitial pulmonary fibrosis, and COPD. The diagnostic segment accounted for 68.93% share of the market in 2017, spurred by the prevalence of breathing diseases such as asthma. But the treatment monitoring segment can exhibit the highest CAGR during the review period to reach a valuation of USD 353 million by 2023. Its valuation in 2018 was suggested to be USD 214.12 million.
Key market end-users include hospitals & clinics, research & academic institutes, diagnostic centers, and home care. The home care segment is projected to enjoy a 9.90% CAGR to reach a valuation of USD 71.14 million by 2023 from USD 44.38 million in 2018.
Spirometry Market Regional Analysis:
The spirometry market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas accounted for 39.74% share in the global market in 2017, followed by Europe and APAC. This can be attributed to economies such as the U.S. which are the earliest adopters of latest technologies coupled with the large patient pool suffering from respiratory disorders. The region is likely to enjoy a 10.25% CAGR over the forecast period.
The Europe spirometry market is expected to enjoy a CAGR similar to the Americas market over the forecast period to touch a valuation of USD 322.33 million by 2023. This can be credited to rising number of asthma cases and ballooned healthcare expenditure of nations such as Germany and France.
The MEA region can experience a respectable CAGR during the review period owing to improvements of healthcare infrastructure and enhanced healthcare budgets of Kuwait, Qatar, and Dubai.
The APAC region is expected to exhibit a 10.94% CAGR over the forecast period owing to high cases of chronic diseases, awareness of respiratory devices, and increased healthcare budgets of developed nations in the region. The growing geriatric populace in China and Japan can contribute to regional market revenue till 2023.
Spirometry MarketCompetitive Dashboard:
Key players in the spirometry market include Smiths Medical Inc. (U.S.), Vitalograph (U.K.), MGC Diagnostics Corporation (U.S.), Hill-Rom Holdings, Inc. (U.S.), Schiller AG (Switzerland), COSMED srl (Italy), Midmark Corporation (U.S.), NDD Medical Technologies, Inc. (U.S.), Carefusion Corporation (U.S.), Nihon Kohden Corporation (Germany), and Koninklijke Philips N.V. (The Netherlands).
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
 Contact:
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels:

Body Contouring Devices and Procedures Market 2020- Global Analysis and Trends by 2023

Market Highlights:
The Global Body Contouring Devices and Procedures Market held a market value of USD 2,103 million in 2017 and is projected to grow at a CAGR of 6.6% over the forecast period.Body contouring is a altering the body part by improving the appearance. It involves the removal or transfer of fat to the body.  
Due to increasing prevalence of obesity across the globe many of the companies are in the race to introduce better treatment for obesity. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market.
Additionally, the growing research and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, the high cost of surgery with advanced technologies may hamper the market growth during the assessment period.
Regional Analysis:
On regional basis, the Americas is anticipated to dominate the global body contouring devices and procedures market  owing to the growing R&D budgets by both government as well as commercial pharmaceutical and biotechnological companies and increasing adoption of advanced technologies in the region.  Europe is expected to hold the second largest position in the global body contouring devices and procedures market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Asia Pacific has served an opportunity for developing body contouring market in this region due to increasing demand for the better treatment and devices and increasing prevalence of disease like diabetes and obesity. The Middle East & Africa has the least share of the global body contouring devices and procedures market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.
Key Players:
Some of the prominent players in the global body contouring devices and procedures market are Cynosure, Inc., Alma Lasers, Alleragan, Syneron Medical Ltd, Bausch Health Companies, Inc, Lumenis, Merz Pharma GmbH & Co., Palomar Medical Technologies Inc., Sound Surgical Technologies LLC., Zeltiq Aesthetics, Chromogenex Technologies LTD, UltraShape Ltd, Fotona, Misonix Inc., Medicis Pharmaceutical Corporation, Sientra Inc., Invasix Ltd, Erchonia Inc, Lutronic.
Segmentation:
The global body contouring devices and procedures market has been segmented into type, procedure, and end user. By type, the market has been segmented into non-invasive & minimally invasive devices and invasive devices. The non-invasive & minimally invasive devices segment is estimated to hold major market share in the global body contouring devices and procedures market due to the huge investments by major market players for the development of advanced technologies and equipment.
Based on procedure, the market has been segmented into non-surgical skin resurfacing, non-surgical skin tightening, cellulite treatment, liposuction, and others. The market, by end user, has been segmented into hospitals & clinics, research institutes & Organization, and others.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:                                    
Akash Anand           
Market Research Future
+1 646 845 9312
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)